Bedell Frazier Investment Counseling LLC lessened its holdings in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 60,481 shares of the company’s stock after selling 1,526 shares during the quarter. AbbVie […]
Detalus Advisors LLC lifted its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 371.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,499 shares of the company’s stock after acquiring an additional 13,785 shares during the period. AbbVie accounts […]
Chicago Partners Investment Group LLC raised its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 4.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 21,640 shares of the company’s stock after buying an additional 876 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in […]
Financial Advisory Group lowered its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 3.1% during the fourth quarter, Holdings Channel.com reports. The firm owned 4,248 shares of the company’s stock after selling 138 shares during the quarter. Financial Advisory Group’s holdings in AbbVie were worth $687,000 as of its most recent SEC filing. Other […]
Victory Capital Management Inc. lowered its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 2.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,209,564 shares of the company’s stock after selling 54,775 shares during the period. Victory Capital Management Inc. […]